A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
Business description not available.
| Metric | TTM | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | 1.0B | 1.0B | 1.0B | 880M | 760M | 583M |
| Net Income | 185M | 185M | 227M | 208M | 155M | 80M |
| EPS | $4.58 | $4.58 | $5.62 | $5.14 | $3.84 | $1.98 |
| Free Cash Flow | 135M | 135M | -99M | 156M | 168M | 110M |
| ROIC | 34.3% | 21.8% | 27.9% | 41.7% | 31.2% | 17.7% |
| Gross Margin | 43.0% | 43.0% | 45.7% | 44.8% | 42.5% | 39.0% |
| Debt/Equity | 0.00 | 0.39 | 0.35 | 0.02 | 0.01 | 0.20 |
| Dividends/Share | $4.00 | $1.40 | $1.41 | $1.37 | $2.60 | $1.48 |
| Operating Income | 238M | 238M | 284M | 239M | 175M | 87M |
| Operating Margin | 23.6% | 23.6% | 27.1% | 27.1% | 23.1% | 14.9% |
| ROE | 30.2% | 30.2% | 38.0% | 40.9% | 33.7% | 22.0% |
| Shares Outstanding | 40M | 40M | 40M | 40M | 40M | 40M |
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 583M | 760M | 880M | 1.0B | 1.0B | 1.0B |
| Gross Margin | 39.0% | 42.5% | 44.8% | 45.7% | 43.0% | 43.0% |
| R&D | -89M | -92M | -95M | -116M | -119M | -119M |
| SG&A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT | 87M | 175M | 239M | 284M | 238M | 238M |
| Op. Margin | 14.9% | 23.1% | 27.1% | 27.1% | 23.6% | 23.6% |
| Net Income | 80M | 155M | 208M | 227M | 185M | 185M |
| Net Margin | 13.7% | 20.4% | 23.6% | 21.7% | 18.4% | 18.4% |
| Non-Recurring | 0 | 0 | 0 | 0 | 0 | 0 |
| Returns on Capital | ||||||
| ROIC | 17.7% | 31.2% | 41.7% | 27.9% | 21.8% | 34.3% |
| ROE | 22.0% | 33.7% | 40.9% | 38.0% | 30.2% | 30.2% |
| ROA | 16.0% | 28.4% | 34.0% | 24.2% | 19.2% | 19.2% |
| Cash Flow | ||||||
| Op. Cash Flow | 110M | 168M | 198M | 3.3M | 193M | 193M |
| Free Cash Flow | 110M | 168M | 156M | -99M | 135M | 135M |
| Owner Earnings | 110M | 168M | 198M | 3.3M | 193M | 193M |
| CapEx | 0 | 0 | 42M | 102M | 57M | 57M |
| Maint. CapEx | 0 | 0 | 0 | 0 | 0 | 0 |
| Growth CapEx | N/A | N/A | N/A | N/A | N/A | 57M |
| D&A | 0 | 0 | 0 | 0 | 0 | 0 |
| CapEx/OCF | N/A | N/A | 21.2% | 3129.4% | 29.7% | 29.7% |
| Capital Allocation | ||||||
| Dividends Paid | 60M | 105M | 111M | 154M | 162M | 162M |
| Dividend Yield | 2.0% | 2.3% | 3.2% | 3.9% | 5.0% | 7.0% |
| Share Buybacks | 0 | 36M | 0 | 0 | 0 | 0 |
| Buyback Yield | 0.0% | 0.8% | 0.0% | 0.0% | 0.0% | 0.0% |
| Stock-Based Comp | N/A | N/A | N/A | N/A | N/A | N/A |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 | 0 |
| Balance Sheet | ||||||
| Net Debt | 6.3M | -38M | -79M | 165M | 205M | -35M |
| Cash & Equiv. | 68M | 41M | 90M | 43M | 35M | 35M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A |
| Debt/Equity | 0.20 | 0.01 | 0.02 | 0.35 | 0.39 | 0.00 |
| Interest Coverage | 12.9 | 20.2 | 19.4 | 15.2 | 10.5 | 10.5 |
| Equity | 361M | 459M | 508M | 598M | 613M | 613M |
| Total Assets | 498M | 544M | 611M | 940M | 966M | 966M |
| Total Liabilities | 136M | 85M | 103M | 342M | 353M | 353M |
| Intangibles | 0 | 0 | 0 | 2.3M | 1.3M | 1.3M |
| Retained Earnings | 372M | 464M | 511M | 601M | 621M | 621M |
| Working Capital | 240M | 263M | 337M | 354M | 398M | 398M |
| Current Assets | 302M | 344M | 429M | 489M | 511M | 511M |
| Current Liabilities | 62M | 82M | 93M | 135M | 113M | 113M |
| Per Share Data | ||||||
| EPS | 1.98 | 3.84 | 5.14 | 5.62 | 4.58 | 4.58 |
| Owner EPS | 2.72 | 4.15 | 4.90 | 0.08 | 4.77 | 4.77 |
| Book Value | 8.95 | 11.36 | 12.56 | 14.81 | 15.18 | 15.18 |
| Cash Flow/Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.59 |
| Dividends/Share | 1.48 | 2.60 | 1.37 | 1.41 | 1.40 | 4.00 |
| Shares Out. | 40.4M | 40.4M | 40.4M | 40.4M | 40.4M | 40.4M |
| Valuation | ||||||
| P/E Ratio | 51.2 | 29.6 | 17.3 | 17.9 | 12.9 | 12.4 |
| P/FCF | 37.2 | 27.3 | 23.0 | N/A | 17.6 | 17.0 |
| EV/EBIT | 47.2 | 26.0 | 14.7 | 14.9 | 10.9 | 9.5 |
| Price/Book | 11.3 | 10.0 | 7.1 | 6.8 | 3.9 | 3.8 |
| Price/Sales | 7.0 | 6.0 | 4.1 | 3.9 | 2.4 | 2.3 |
| FCF Yield | 2.7% | 3.7% | 4.3% | -2.4% | 5.7% | 5.9% |
| Market Cap | 4.1B | 4.6B | 3.6B | 4.1B | 2.4B | 2.3B |
| Avg. Price | 75.45 | 110.51 | 84.43 | 97.84 | 80.26 | 56.95 |
| Year-End Price | 101.23 | 113.48 | 88.72 | 100.88 | 58.90 | 56.95 |
MELEXIS passes 7 of 9 quality checks, indicating strong fundamentals.
MELEXIS trades at 12.4x trailing earnings, compared to its 15-year median P/E of 17.9x, suggesting it is currently Fair relative to its historical range. On a free-cash-flow basis, the stock trades at 17.0x vs a median of 25.2x. The company's 5-year average ROIC is 28.1% with a gross margin of 43.0%. Total shareholder yield (dividends) is 7.0%. At current prices, the estimated annualized return to fair value is -4.5%.
MELEXIS (MELE-BR) has a current P/E ratio of 12.4, compared to its historical median P/E of 17.9. The stock is currently considered Fair based on its historical valuation range.
MELEXIS (MELE-BR) has a 5-year average return on invested capital (ROIC) of 28.1%. This indicates strong capital allocation and a potential competitive advantage.
MELEXIS (MELE-BR) has a market capitalization of $2.3B. It is classified as a mid-cap stock.
Yes, MELEXIS (MELE-BR) pays a dividend with a trailing twelve-month yield of 7.02%.
Based on historical P/E analysis, MELEXIS (MELE-BR) appears fair. The current P/E of 12.4 is 31% below its historical median of 17.9. The estimated fair value CAGR (P/E method) is 19.9%.
MELEXIS (MELE-BR) reported annual revenue of $1.0 billion in its most recent fiscal year, based on SEC EDGAR filings.
MELEXIS (MELE-BR) has a net profit margin of 18.4%. This is a healthy margin.
MELEXIS (MELE-BR) generated $135 million in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
MELEXIS (MELE-BR) has a debt-to-equity ratio of 0.39. This indicates a conservatively financed balance sheet.
MELEXIS (MELE-BR) reported earnings per share (EPS) of $4.58 in its most recent fiscal year.
MELEXIS (MELE-BR) has a return on equity (ROE) of 30.2%. This indicates the company generates strong returns for shareholders.
MELEXIS (MELE-BR) has a 5-year average gross margin of 43.0%. This indicates decent pricing power.
The Ledger Terminal provides 5 years of financial data for MELEXIS (MELE-BR), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
MELEXIS (MELE-BR) has a book value per share of $15.18, based on its most recent annual SEC filing.